Thomas Carmody
About
Thomas Carmody is a scholar working on Psychiatry and Mental health, Experimental and Cognitive Psychology and Pharmacology.
According to data from OpenAlex, Thomas Carmody has authored 209 papers receiving a total of 11.5k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Psychiatry and Mental health, 64 papers in Experimental and Cognitive Psychology and 61 papers in Pharmacology. Recurrent topics in Thomas Carmody's work include Treatment of Major Depression (60 papers), Mental Health Research Topics (47 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (33 papers). Thomas Carmody is often cited by papers focused on Treatment of Major Depression (60 papers), Mental Health Research Topics (47 papers) and Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes (33 papers). Thomas Carmody collaborates with scholars based in United States, Singapore and China. Thomas Carmody's co-authors include A. John Rush, Madhukar H. Trivedi, Martin B. Keller, Daniel N. Klein, Bruce A. Arnow, Susan G. Kornstein, James H. Kocsis, Rachel Manber, John C. Markowitz and Michael E. Thase and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.
In The Last Decade
Thomas Carmody
198 papers receiving 11.1k citations
Hit Papers
Peers — A (Enhanced Table)
Peers by citation overlap · career bar shows stage (early→late) cites · hero ref
| Name | h | Career | Trend | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|---|---|
| Thomas Carmody United States | 50 | 3.9k | 3.0k | 3.0k | 2.9k | 1.5k | 209 | 11.5k | ||
| Eric J. Lenze United States | 56 | 2.7k 0.7× | 3.4k 1.1× | 2.1k 0.7× | 2.8k 1.0× | 1.9k 1.2× | 352 | 12.0k | ||
| Giovanni A. Fava Italy | 69 | 5.0k 1.3× | 4.4k 1.5× | 2.9k 1.0× | 5.2k 1.8× | 876 0.6× | 338 | 16.7k | ||
| Jonathan E. Alpert United States | 66 | 3.7k 0.9× | 3.3k 1.1× | 4.5k 1.5× | 3.0k 1.0× | 1.8k 1.1× | 233 | 12.7k | ||
| Mario Maj Italy | 56 | 4.5k 1.1× | 1.4k 0.5× | 1.5k 0.5× | 3.9k 1.4× | 2.0k 1.3× | 301 | 11.7k | ||
| Gábor S. Ungvári China | 58 | 4.9k 1.2× | 2.9k 1.0× | 1.8k 0.6× | 4.0k 1.4× | 1.6k 1.1× | 557 | 13.9k | ||
| G.K. Balasubramani United States | 41 | 1.9k 0.5× | 2.5k 0.8× | 3.7k 1.3× | 1.4k 0.5× | 1.0k 0.7× | 143 | 8.8k | ||
| Kay Wilhelm Australia | 56 | 2.5k 0.6× | 1.8k 0.6× | 1.6k 0.5× | 3.9k 1.3× | 1.3k 0.8× | 243 | 10.6k | ||
| André F. Carvalho Canada | 58 | 4.5k 1.1× | 1.5k 0.5× | 1.5k 0.5× | 3.8k 1.3× | 1.2k 0.8× | 226 | 13.8k | ||
| Philip Boyce Australia | 56 | 2.5k 0.6× | 1.6k 0.5× | 1.3k 0.4× | 3.4k 1.2× | 971 0.6× | 235 | 10.8k | ||
| Sati Mazumdar United States | 46 | 2.7k 0.7× | 2.2k 0.8× | 1.9k 0.7× | 1.9k 0.6× | 1.3k 0.8× | 155 | 8.4k |
Countries citing papers authored by Thomas Carmody
Since
Specialization
Citations
This map shows the geographic impact of Thomas Carmody's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Carmody with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Carmody more than expected).
Fields of papers citing papers by Thomas Carmody
Since
Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences
This network shows the impact of papers produced by Thomas Carmody. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Carmody. The network helps show where Thomas Carmody may publish in the future.
Co-authorship network of co-authors of Thomas Carmody
This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Carmody. A scholar is included among the top collaborators of Thomas Carmody based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Carmody. Thomas Carmody is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
1.
Sen, Indrani, Sandy Vang, M Ryba, et al.. (2024). Midterm outcomes of endoscopic-assisted brachial-basilic arteriovenous fistula creation. Journal of Vascular Surgery. 79(5). A17–A18.
2.
Li, Michael J., Thomas R. Belin, Thomas Carmody, et al.. (2024). Extended observation of reduced methamphetamine use with combined naltrexone plus bupropion in the ADAPT‐2 trial. Addiction. 119(10). 1840–1845.
3.
Okafor, Chukwuemeka N., Thomas Carmody, Angela L. Stotts, et al.. (2024). Sociodemographic and patient reported outcomes by racial and ethnicity status among participants in a randomized controlled trial for methamphetamine use disorder. SHILAP Revista de lepidopterología. 11. 100230–100230.
4.
Haley, Charlotte, Betsy D. Kennard, David W. Morris, et al.. (2023). The Quick Inventory of Depressive Symptomatology, Adolescent Version (QIDS-A17): A Psychometric Evaluation. Neuropsychiatric Disease and Treatment. Volume 19. 1085–1102.
5.
Levander, Ximena A., Thomas Carmody, Ryan Cook, et al.. (2023). A gender‐based secondary analysis of the ADAPT‐2 combination naltrexone and bupropion treatment for methamphetamine use disorder trial. Addiction. 118(7). 1320–1328.
6.
Raval, Vyom, Abu Minhajuddin, Thomas Carmody, et al.. (2022). BLENDS: Augmentation of Functional Magnetic Resonance Images for Machine Learning Using Anatomically Constrained Warping. Brain Connectivity. 13(2). 80–88.
7.
Kaiser, Roselinde H., Henry W. Chase, Mary L. Phillips, et al.. (2022). Dynamic Resting-State Network Biomarkers of Antidepressant Treatment Response. Biological Psychiatry. 92(7). 533–542.
8.
Rethorst, Chad D., Steven S. Henley, Thomas Carmody, et al.. (2021). Moderators of treatment response to exercise in participants with stimulant use disorder: Exploratory results from the Stimulant Reduction using Dosed Exercise (STRIDE)CTN-0037 study. Mental health and physical activity. 21. 100421–100421.
9.
Ang, Yuen‐Siang, Gerard E. Bruder, John G. Keilp, et al.. (2020). Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychological Medicine. 52(13). 2441–2449.
10.
Trombello, Joseph M., Michael Killian, Bruce D. Grannemann, et al.. (2019). The Concise Health Risk Tracking-Self Report: Psychometrics within a placebo-controlled antidepressant trial among depressed outpatients. Journal of Psychopharmacology. 33(2). 185–193.
11.
Jha, Manish K., Abu Minhajuddin, Cherise Chin-Fatt, et al.. (2019). Sex differences in the association of baseline c-reactive protein (CRP) and acute-phase treatment outcomes in major depressive disorder: Findings from the EMBARC study. Journal of Psychiatric Research. 113. 165–171.
12.
Trombello, Joseph M., Diego A. Pizzagalli, Myrna M. Weissman, et al.. (2018). Characterizing anxiety subtypes and the relationship to behavioral phenotyping in major depression: Results from the EMBARC study. Journal of Psychiatric Research. 102. 207–215.
13.
Rethorst, Chad D., Marisa Toups, Paul A. Nakonezny, et al.. (2012). Pro-inflammatory cytokines as predictors of antidepressant effects of exercise in major depressive disorder. Molecular Psychiatry. 18(10). 1119–1124.
14.
Trivedi, Madhukar H., Tracy L. Greer, Timothy S. Church, et al.. (2011). Exercise as an Augmentation Treatment for Nonremitted Major Depressive Disorder. The Journal of Clinical Psychiatry. 72(5). 677–684.
15.
Denton, Wayne H., Thomas Carmody, A. John Rush, et al.. (2009). Dyadic discord at baseline is associated with lack of remission in the acute treatment of chronic depression. Psychological Medicine. 40(3). 415–424.
16.
Hughes, Carroll W., et al.. (2008). Executive Functioning in Children and Adolescents with Major Depressive Disorder. Child Neuropsychology. 15(1). 85–98.
17.
Brown, E. Sherwood, Michelle Murray, Thomas Carmody, et al.. (2008). The Quick Inventory of Depressive Symptomatology-Self-report: a psychometric evaluation in patients with asthma and major depressive disorder. Annals of Allergy Asthma & Immunology. 100(5). 433–438.
18.
Emslie, Graham J., Beth D. Kennard, Taryn L. Mayes, et al.. (2008). Fluoxetine Versus Placebo in Preventing Relapse of Major Depression in Children and Adolescents. American Journal of Psychiatry. 165(4). 459–467.
19.
Byerly, Matthew, et al.. (2007). Validity of Electronically Monitored Medication Adherence and Conventional Adherence Measures in Schizophrenia. Psychiatric Services. 58(6). 844–847.
20.
Carmody, Thomas, A. John Rush, Ira H. Bernstein, et al.. (2006). Making clinicians lives easier: Guidance on use of the QIDS self-report in place of the MADRS. Journal of Affective Disorders. 95(1-3). 115–118.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.
Explore authors with similar magnitude of impact
Breakdown of academic impact, for papers by Eric J. Lenze Breakdown of academic impact, for papers by Giovanni A. Fava Breakdown of academic impact, for papers by Jonathan E. Alpert Breakdown of academic impact, for papers by Mario Maj Breakdown of academic impact, for papers by Gábor S. Ungvári Breakdown of academic impact, for papers by G.K. Balasubramani Breakdown of academic impact, for papers by Kay Wilhelm Breakdown of academic impact, for papers by André F. Carvalho Breakdown of academic impact, for papers by Philip Boyce Breakdown of academic impact, for papers by Sati Mazumdar